Results per Page:
A beacon of light in the dark world of rare cancers
From Drs. Ajay Gopal, Christina Poh, Michi Shinohara and colleagues, Clinical Research Division and University of Washington
Dr. Ajay Gopal named Stephen H. Petersdorf Endowed Chair in Cancer Care at UW Medicine
Chair honors his dedication to improving patient care through research
Diffuse large B cell lymphoma gets new first line therapy
From the Gopal laboratory, Clinical Research Division, and the Smith laboratory, University of Washington Medical Oncology
One family, two sides of cancer
Basic scientist Dr. Wenying Shou’s parents were both treated for — and cured of — their cancers. The similarities end there.
Paulovich Lab's proteomic platform presented at personalized medicine conference
Celebrating faculty and staff achievements
New drug shows promise in treating slow-growing non-Hodgkin lymphomas
Idelalisib could be on the market later this year, pending FDA approval
New drug shows promise in treating indolent non-Hodgkin lymphomas - Fred Hutchinson Cancer Research Center
Idelalisib could be on the market later this year, pending FDA approval
High-dose Vorinost effective treating lymphomas - Fred Hutchinson Cancer Research Center
Results of phase 1 clinical trial lead way to use of new class of drugs to treat aggressive blood cancer
Precision punch to lymphoma
Ajay Gopal and colleagues use antibodies to deliver targeted, less toxic treatment to lymphoma's most vulnerable victims